A Clinical Trial to Evaluate the Efficacy and Safety of Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide as a First-line Treatment in Naïve Patients With HIV-1 Infection With Severe Immunosuppression

NCT03693508 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections
Severe Immunosuppression

Interventions

DRUG: Genvoya®

Sponsor

Fundacion SEIMC-GESIDA

Collaborators

[object Object]